API | ardeparin

ardeparin (normiflo) Report issue

Small molecule Approved ^FDA

ChEMBL DrugBank Drugs@FDA MeSH PubChem

Active Ingredient History

NOW

Ardeparin is an anticoagulant. It was used for the prevention of deep vein thrombosis, but was withdrawn from the US market in 2000 for reasons unrelated to safety or efficacy. ^Wikipedia

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
ardeparin sodium

More Chemistry

Pharmacology

Mechanism of Action:
- Antithrombin-III (Homo sapiens) ^UniProt
Multi-specific: Missing data
Black Box: No
Availability: Discontinued
Delivery Methods: Parenteral
Pro Drug: No

ardeparin | ardeparin sodium | normiflo | wy-90493 rd

Organizations (2)

Research & Development (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (1)

Approved Indications (1)

Upper Extremity Deep Vein Thrombosis (approved 1997)

Experimental Indications - Clinical Trial Phases 1-4 (0)

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue